Good morning.
Interesting link with all the news registered
at the annual ASCO-GU meeting held this week of February.
Cheers
Annual summary ASCO-GU February-2020 - Advanced Prostate...
Annual summary ASCO-GU February-2020
Written by
fco1969
To view profiles and participate in discussions please or .
Not what you're looking for?
You may also like...
Abiraterone + Olaparib: ASCO GU 2024 Highlights: BRCAAway Trial
bad at all...
https://www.urotoday.com/video-lectures/asco-gu-2024/video/mediaitem/3829-asco-gu-202
ARASENS: Darolutamide + ADT + Docetaxel may become new SOC for mHSPC - from ASCO GU Symposium 2022
toxicity (pub. in NEJofM and wrap-up edition of ASCO GU 2022 Symposium). With such dramatic results,
FDA Approves Darolutamide Plus Docetaxel for Metastatic Hormone-Sensitive Prostate Cancer
ensitive-prostate-cancer
More info:
https://www.urotoday.com/conference-highlights/asco-gu-2022/
Join ASCO as a Patient Advocate for Free
Cannabis Instead of Opioids for Chronic Pain reduction - summary of research from goodrx
New Health Plans for 2020
Developments since July 2020
